300463.SZ
Maccura Biotechnology Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 9.26
+0.65%Year over year
Reported trailing growth
- Revenue
- -12.6%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- +97.5%
- Operating cash flow
- +1.5%
Forward estimates
Based on analyst estimates
- Revenue
- -8.3%
- EBITDA
- +522.5%
- EPS
- +2268.8%
Three-year CAGR
- Revenue
- -15.6%
- EBITDA
- -34.7%
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- +55.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026